Clinical Outcomes of CD7 CAR-T Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Patients.
- DOI
- 10.1002/hon.70081
- Published
- 2025 May
- Container
- Hematological oncology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/hon.70081,
title = {Clinical Outcomes of CD7 CAR-T Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Patients.},
author = {Xiao J and Liu Y and Shen Y and Li J and Wang Y and Chen S and Tang X and Yang L and Zhou B and Xu Y and Wu D},
year = {2025},
journal = {Hematological oncology},
doi = {10.1002/hon.70081},
url = {https://doi.org/10.1002/hon.70081}
}RIS
TY - JOUR TI - Clinical Outcomes of CD7 CAR-T Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Patients. AU - Xiao J AU - Liu Y AU - Shen Y AU - Li J AU - Wang Y AU - Chen S AU - Tang X AU - Yang L AU - Zhou B AU - Xu Y AU - Wu D PY - 2025 JO - Hematological oncology DO - 10.1002/hon.70081 UR - https://doi.org/10.1002/hon.70081 ER -
APA
J, X., Y, L., Y, S., J, L., Y, W., S, C., X, T., L, Y., B, Z., Y, X., & D, W. (2025). Clinical Outcomes of CD7 CAR-T Cell Therapy in Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Patients.. Hematological oncology. https://doi.org/10.1002/hon.70081
Source records
- pubmed · retrieved 2026-09-25T20:14:43.483Z